We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 12,591

Down with the chips when the chips are down: Kelly v. Cape Cod Potato Chip Company, Inc
  • Shook Hardy & Bacon LLP
  • USA
  • January 29 2015

In a recent decision from the United States District Court for the Western District of Missouri, Judge Whipple demonstrated that he is indeed "down


Proposed personal care products Safety Act could significantly expand FDA authority over cosmetics
  • Shook Hardy & Bacon LLP
  • USA
  • May 7 2015

U.S. Sens. Dianne Feinstein (D-Calif.) and Susan Collins (R-Maine) introduced the Personal Care Products Safety Act (S. 1014) on April 20, 2015. The


Medical monitoring class action rejected at pleading stage
  • Shook Hardy & Bacon LLP
  • USA
  • April 3 2015

A federal court recently rejected a proposed medical monitoring class action brought by alleged Pepsi drinkers. The case reminds readers of the


First of its kind Arkansas ruling limits extent of auto warranties
  • Arent Fox LLP
  • USA
  • April 24 2015

In what he said appears to be a first-of-its-kind decision in the state, an Arkansas federal judge found Thursday that automotive warranties do not


FDA warns supplement manufacturers over unapproved stimulant
  • Shook Hardy & Bacon LLP
  • USA
  • May 7 2015

The U.S. Food and Drug Administration (FDA) has sent warning letters to five companies for product misbranding because the dietary supple- ments they


Technology companies: when a product complaint arises, will your insurance cover the claims?
  • Nossaman LLP
  • USA
  • May 5 2015

Sometimes, technology products contain flaws. Purchasers may complain to the manufacturer about the flawed products, and some complaints become


Court rejects preemption raised to defend challenge to withdrawn drug.
  • Jenner & Block
  • USA
  • April 30 2015

In Guvenoz v. Target Corp., No. 1-13-3940 (Ill. App. 1st Dist. 2015), the Illinois Appellate Court addressed certified questions in an interlocutory


OPDP to study the impact of comparative pricing information in DTC and professional prescription ads
  • Loeb & Loeb LLP
  • USA
  • May 7 2015

The agency will investigate how prescription drug product perceptions are impacted by the inclusion of price comparison information and supplementary


FDA issues guidance documents on how it considers balancing premarket and postmarket data collection during PMA reviews in a bid to accelerate the approval of new breakthrough devices
  • Loeb & Loeb LLP
  • USA
  • May 7 2015

The regulator explains how it determines when it's appropriate to increase reliance on postmarket collection to reduce the extent of premarket


Otsuka’s orphan drug exclusivity claims: FDA rips off the band-aid early
  • McGuireWoods LLP
  • USA
  • April 24 2015

Sometimes you need to get in front of the issue earlyOn April 20, 2015, FDA filed a brief in Opposition to Plaintiff’s Motion for Temporary